CEO of vaccine maker sold $10 million in stock before company ruined J&J doses
The chief of Emergent BioSolutions made the sales by exercising stock options weeks before the company’s share price tumbled.
Full Article
CEO of vaccine maker sold $10 million in stock before company ruined J&J doses
Washington Post
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Sanatana Resources, Golden Tag Resources, Else Nutrition, PlantX Life, Lingo Media, HealthLynked, The Valens Company UPDATE …
Proactive Investors
Sanatana Resources Inc (CVE:STA) (OTCMKTS:SADMF) announced the appointment of Tom Obradovich to the company’s board of directors...
-
NA Proactive news snapshot: PlantX Life, Lingo Media, HealthLynked, The Valens Company UPDATE …
Proactive Investors
-
A vaccine maker ruined 15 million doses. Its CEO sold $11 million of stock before that was public
Upworthy
-
A U.S. vaccine maker ruined 15 million doses. Its CEO sold US$11 million of stock before that was public
CTV News
-
Nasdaq and S&P 500 hit record highs, while the Dow soured in afternoon trading
Proactive Investors
Advertisement
More coverage
CEO Sued After Selling Off $10 Million In Stock Before Company Ruined 15 Million Vaccine Doses
Daily Caller
The stock is now worth $5.5 million
-
US benchmarks mixed ahead of big tech earnings
Proactive Investors
-
The CEO of Emergent, the company that ruined 15 million J&J vaccine doses, sold more than $10 million in stock before prices fell
Business Insider
-
J&J records $100 million in sales from the COVID-19 vaccine
SeattlePI.com
-
Wall Street on the back foot all day as rising virus cases rattled investors
Proactive Investors